Torunn Elisabeth Tjelle

Torunn Elisabeth Tjelle currently serves as a Special Advisor at Kreftforeningen (Norwegian Cancer Society) since October 2019, with additional responsibilities as Acting Head of Section and Special Adviser, focusing on the management of cancer research funding. Prior experience includes a role as Senior Scientist at the Norwegian Institute of Public Health from February 2017 to May 2021, where Torunn prioritized quality and economic efficiency in health services through methodical reviews. A diverse background encompasses project management for medical device development at RemovAid AS, coordination for Normisjon's Martin Luther College initiative, and extensive research in various scientific roles, including a Postdoctoral Fellowship at Oslo University Hospital and a Senior Research Scientist position at Inovio Pharmaceuticals Inc. Torunn holds a PhD and a Master's degree in Cell/Cellular and Molecular Biology from the University of Oslo.